Introduction {#s1}
============

The gonadotropin-releasing hormone (GnRH) neurons represent the final output cells of a complex neuronal network that integrates a wide variety of internal and external factors to control the fertility of the individual ([@bib14]). In females, these neurons secrete GnRH into the pituitary portal circulation either as discrete pulses approximately once every hour or as a prolonged surge at the mid-point of the ovarian cycle to initiate ovulation ([@bib13]; [@bib21]; [@bib23]).

The GnRH neurons exhibit a bipolar morphology with synaptic inputs clustered around the soma and proximal dendrites ([@bib2]; [@bib24]; [@bib30]) and the action potential initiation site located 50--100 μm down one of the dendritic processes ([@bib17]; [@bib20]; [@bib38]). To date, synaptic integration within this soma-dendritic zone of the GnRH neuron has been the prime focus of attention in understanding how these cells generate pulse and surge modes of GnRH release. However, recent studies in the mouse have highlighted that one or both of the dendritic processes arising from a GnRH neuron can project for over 4000 μm before terminating in short neurosecretory axons within the secretory zone of the median eminence ([@bib16]; [@bib32]). Unusually, these processes conduct action potentials from the soma-dendritic zone but also receive synaptic inputs, with their blended dendritic/axonal properties leading them to be termed 'dendrons' ([@bib16]). These morphological studies have raised the possibility that synaptic inputs directed at GnRH neuron distal dendrons immediately adjacent to the median eminence secretory zone play a role in regulating GnRH secretion. The present studies were aimed at examining the significance and physiological relevance of the GnRH neuron distal dendron in vivo.

Results {#s2}
=======

Synaptic densities at the soma-dendritic and distal dendron zones of the GnRH neuron {#s2-1}
------------------------------------------------------------------------------------

While it has been possible to observe synapses on the GnRH neuron distal dendron using electron microscopy ([@bib32]), their potential significance is unknown. To examine the relative density of synaptic inputs at the dendron compared with more proximal compartments of the GnRH neuron, we used expansion microscopy ([@bib4]; [@bib5]) to generate high-resolution images of synaptophysin-immunoreactive terminals apposing GnRH neurons in adult diestrous female GnRH-GFP mice (N = 4)([Figure 1](#fig1){ref-type="fig"}). Expansion microscopy operates on the principal of isotropic swelling of the tissue specimen (typically by 4--5 times) before undertaking regular confocal microscopy; thereby providing \~70 nm resolution in brain tissue ([@bib46]). Although synaptophysin can be used to reliably mark almost all presynaptic terminals, a global post-synaptic marker is not available. Hence, to be able to define a synapse using only presynaptic and cytoplasmic labels, we first visualized GABA~A~ receptors on GnRH-GFP neurons by labelling for GFP alongside the pre- and post-synaptic markers vesicular GABA transporter (VGAT) and gephyrin, respectively ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We analyzed 25 'side-on' profiles where VGAT and gephyrin were opposed to one another, thereby, defining a synapse ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). This revealed that the overlap between cytoplasmic GFP and the presynaptic marker VGAT must be \>0.23 μm (0.95 μm post-expansion) to represent a synapse; the gephyrin signal was contained within the GFP signal and all 25 synapses had an overlap in VGAT and GFP signals \> 0.23 μm ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). This value (0.23 μm) does not reflect the size of the synaptic cleft but rather the minimum overlap between the irregularity of pre- and cytoplasmic compartments at the synapse when viewed in 2D with this resolution. As not all appositions can be viewed in a 'side-on' profile, we also examined appositions in the 'face view' orientation that require scanning in the z-axis ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Intensity profiles from a total of 12 GABAergic synapses were plotted with synapses found to have \>0.42 μm (1.75 μm post-expansion) overlap in VGAT and GFP signals in the z-axis ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). These observations set the parameters for determining synapses on GnRH-GFP neurons using the global presynaptic marker synaptophysin and GFP as the cytoplasmic label.

![Expansion microscopy views of synaptic appositions at the GnRH neuron proximal dendrite and distal dendron.\
Schematic showing the morphology of a hypophysiotropic GnRH neuron with its soma-proximal dendrites located in the rostral preoptic area (rPOA) and the distal dendron and short axon branches in the median eminence (ME). Synaptic density analysis was undertaken on 60 μm-lengths of proximal dendrite and 15 μm-lengths of distal dendron. (**A**) Expansion microscopy view of a proximal dendrite (green) with surrounding synaptophysin puncta (red). (**B**) shows rotated 3D reconstruction with white lines indicating three appositions that were examined. (**C**) The side-on relative fluorescence intensity profiles are shown for the three appositions. (i) and (iii) represent synaptic appositions whereas (ii) indicates apposing profiles with no overlap that do not represent a synapse. (**D**) Expansion microscopy view of distal dendrons (green) with surrounding red synaptophysin puncta. (**E**) shows rotated 3D reconstruction with white lines indicating three appositions that were examined. (**F**) The relative fluorescence intensity profiles are shown for the three appositions. (ii) and (iii) represent synaptic appositions, whereas (i) indicates apposing profiles with no overlap that do not represent a synapse. Scale bars show pre-expansion values with expanded size in brackets. X-axis plots show pre- expansion values.](elife-53945-fig1){#fig1}

In agreement with electron microscopic studies ([@bib22]), only a very few synaptophysin-immunoreactive profiles abutting GnRH neuron dendrites and cell bodies met the criteria for a synapse (e.g. [Figure 1](#fig1){ref-type="fig"}.C(ii) and F(i) do not). The density of synaptophysin-immunoreactive elements forming synaptic appositions along the first 60 μm (252 μm post-expansion) of the primary dendrite (soma-dendritic zone) was 0.8 ± 0.3 synapses/10 μm membrane with 95% of dendrites (N = 4 female mice) exhibiting synapses ([Figure 1A--C](#fig1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). The same analysis at the level of the distal dendron found 2.0 ± 0.2 synapses/10 μm with 53% of dendritic elements having at least one synapse along the 15 μm (63 μm post-expansion) segment analysed (N = 4) ([Figure 1D--F](#fig1){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). These observations indicate a 2.5-fold higher density of synaptic inputs onto GnRH neuron distal dendrons compared to their soma-dendritic zone suggesting a physiologically important role.

###### Quantitative analysis of synaptic appositions on the proximal and distal dendrites of GnRH neurons in diestrus female mice (N = 4).

For proximal dendrites, 60 µm of dendrite was measure in each case, whereas 15 µm lengths were examined for distal dendrites.

  **GnRH proximal dendrites**                          
  ---------------------------------------------------- -----------
  No. of dendrites counted                             38
  Percentage of dendrites with synaptophysin contact   95%
  No. of synaptophysin contacts with GnRH dendrite     183
  Synaptic density per 10 µm                           0.8 ± 0.3
  GnRH Distal Dendrites                                
  No. of dendrites counted                             211
  Percentage of dendrites with synaptophysin contact   53%
  No. of synaptophysin contacts with GnRH dendrite     330
  Synaptic density per 10 µm                           2.0 ± 0.2

To understand the roles of electrical activity at these two dendritic domains in regulating GnRH secretion, a series of targeted inhibitory chemogenetic and optogenetic studies were undertaken in ovariectomized (OVX) female mice that display robust pulsatile LH secretion, and in OVX, estradiol + progesterone-treated (OVX+E+P) female mice that exhibit a time-locked LH surge at the time of lights off ([Figure 2---figure supplement 1A--C](#fig2s1){ref-type="fig"}). As the GnRH neurons elaborate very long projections within the hypothalamus, it is possible to selectively modulate their proximal soma-dendritic domains within the rostral preoptic area (rPOA) or their distal dendrons lying adjacent to the median eminence (ME) within the mediobasal hypothalamus (MBH)([Figure 1](#fig1){ref-type="fig"}).

Global suppression of GnRH neuron activity abolishes the LH surge and dampens pulsatile LH secretion {#s2-2}
----------------------------------------------------------------------------------------------------

In the first series of experiments, we sought to establish the effects on LH secretion of suppressing activity within all compartments of the hypophysiotropic GnRH neurons projecting to the ME. GnRH-Cre and control wild-type mice were injected with AAV2-Retro-hSyn-DIO-hM4D(Gi)-mCherry into the ME to enable retrograde targeting of hM4Di to the hypophysiotropic GnRH neuron population ([Figure 2A](#fig2){ref-type="fig"}; [@bib3]). Intraperitoneal or central administration of CNO selectively activates hM4D(Gi) receptors resulting in the activation in inward-rectifying potassium channels that suppress electrical excitability ([@bib39]; [@bib40]). Dual label immunohistochemistry showed that 64 ± 2.6% of rPOA GnRH neurons expressed hM4Di-mCherry ([Figure 2B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}) (N = 6). Prior estimates indicate that \~70% of rPOA GnRH neurons are hypophysiotropic ([@bib3]; [@bib28]). A small number of cells (9 ± 1.2%) immunoreactive for mCherry but not GFP were detected and presumably represent GnRH neurons with low expression of GFP. No mCherry was detected in wild-type mice. Initial studies using hourly tail-tip bleeding in OVX+E+P wild-type and GnRH-Cre mice that had not received AAV injections demonstrated that a LH surge commenced between 17:00 and 18:00 hr ([Figure 2---figure supplement 1A--C](#fig2s1){ref-type="fig"}). As such, subsequent LH surge studies employed four blood samples taken at 16:00 (baseline) and at 19:00, 20:00 and 21:00 hr in each mouse to test for the presence of an LH surge.

![Chemogenetic inhibition of GnRH neurons by intraperitoneal (iP) injection of CNO suppresses both the surge and pulse profiles of LH secretion.\
(**A**) Schematic showing experimental protocol with GnRH-Cre mice injected with Cre-dependent Flex-hM4D(Gi)-mCherry AAVs bilaterally into the region of the median eminence and CNO given by IP injection. MS, medial septum. CNO, Clozapine N-oxide. (**B**) Fluorescence images of GnRH neurons expressing GnRH (green) and mCherry (red) in GnRH::Flex-hM4D(Gi)-mCherry mice. Scale bar, 20 μm. (**C,D**) LH profiles for all of the wild-type (WT) OVX+E+P mice given saline control (C, n = 9) or CNO (D, n = 11). (**E,F**) LH profiles for all of the GnRH-Cre OVX+E+P mice given saline control (**E**, n = 12) or CNO (**F**, n = 11). (**G**) Mean (± SEM) LH levels for the four experimental groups. \*p\<0.05, \*\*\*p\<0.001, two-way repeated measures ANOVA with Holm-Sidak test. (**H-M**) Representative examples of pulsatile LH secretion in OVX GnRH-Cre mice given IP saline (**H,I**) or CNO (**J,K**). LH pulses are indicated by asterisks. (**L,M**) Mean (± SEM) amplitude and frequency of LH pulses in saline (n = 6) and CNO (n = 6). \*\*\*p\<0.001 Mann-Whitney U-tests.](elife-53945-fig2){#fig2}

In the first experiment, AAV-injected OVX+E+P wild-type and GnRH-Cre mice were given intraperitoneal saline or CNO at 16:00 hr. Whereas an LH surge occurred in all saline- (N = 9) and CNO- (N = 11) treated wild-type mice ([Figure 2C,D,G](#fig2){ref-type="fig"}), as well as saline-treated GnRH-Cre mice (N = 12)([Figure 2E,G](#fig2){ref-type="fig"}), the LH surge was abolished in CNO-treated GnRH-Cre mice (N = 11)([Figure 2F,G](#fig2){ref-type="fig"}). Mean LH levels in all three surging groups ([Figure 2G](#fig2){ref-type="fig"}) were the same as those observed in mice that had not received AAV injections ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}), while LH levels were significantly reduced at both 19:00 (p\<0.001, two-way repeated ANOVA) and 20:00 time points in CNO-treated GnRH-Cre mice (p\<0.05, two-way repeated ANOVA) ([Figure 2G](#fig2){ref-type="fig"}).

To next assess the effects of global GnRH neuron inhibition on pulsatile LH secretion, the same experimental strategy was undertaken in AAV-injected OVX GnRH-Cre mice. Three-minute blood samples were taken from the tail tip of mice for 2 hr with saline or CNO given 1 hr beforehand. Mice treated with saline exhibited a normal pulsatile pattern of LH release with \~3 ng/ml amplitude pulses occurring every \~15 min (N = 6)([Figure 2H,I,L,M](#fig2){ref-type="fig"}). In contrast, mice treated with CNO exhibited much reduced LH levels with significantly fewer and small amplitude (\~0.5 ng/ml) LH pulses (N = 6)(p\<0.001,Mann-Whitney test)([Figure 2J--M](#fig2){ref-type="fig"}). Mean levels of LH were 2.7 ng/ml in saline and 0.8 ng/ml (p\<0.001, Mann-Whitney test) in CNO-treated mice ([Figure 3---figure supplement 1B,C](#fig3s1){ref-type="fig"}). Together, these studies demonstrate that the chemogenetic inhibition of the entire hypophysiotropic GnRH neuron prevents the occurrence of the LH surge and substantially reduces pulsatile secretion.

Suppression of excitability at GnRH neuron distal dendrons and axons abolishes the LH surge and dampens pulsatile LH secretion {#s2-3}
------------------------------------------------------------------------------------------------------------------------------

In these experiments, GnRH-Cre mice were injected with AAV2-Retro-hSyn-DIO-hM4D(Gi)-mCherry in exactly the same manner as above but CNO was injected directly into the MBH ([Figure 3A](#fig3){ref-type="fig"}) to assess the importance of GnRH neuron distal dendron and axon excitability in the different LH secretion modes. Following AAV retrograde transport to the cell body, hM4Di-mCherry is expressed throughout the GnRH neuron including the distal dendron and axons in the ME ([Figure 3B](#fig3){ref-type="fig"}). Injection of saline into the MBH of AAV-injected OVX+E+P GnRH-Cre mice (N = 12) had no effect on the occurrence of the LH surge ([Figure 3C,E](#fig3){ref-type="fig"}), whereas injection of CNO (N = 12) abolished the LH surge in all mice ([Figure 3D,E](#fig3){ref-type="fig"}). LH levels were significantly reduced at 19:00, 20:00 and 21:00 time points in CNO-treated GnRH-Cre mice (p\<0.001, two-way repeated ANOVA) ([Figure 3E](#fig3){ref-type="fig"}).

![Chemogenetic inhibition of GnRH neuron distal dendron activity suppresses both the surge and pulse profiles of LH secretion.\
(**A**) Schematic showing experimental protocol with GnRH-Cre mice injected with Cre-dependent Flex-hM4D(Gi)-mCherry AAVs bilaterally into the region of the median eminence and CNO given into the same region. MS, medial septum. CNO, Clozapine N-oxide. (**B**) Fluorescence images of GnRH neuron projections in the vicinity of the median eminence expressing GnRH (green) and mCherry (red) in GnRH::Flex-hM4D(Gi)-mCherry mice. Scale bar, 20 μm. (**C,D**) LH surge profiles in all GnRH-Cre OVX+E+P female mice following MBH injection of saline ([**C**]{.smallcaps}, n = 12) or CNO (**D**, n = 12). (**E**) Mean (± SEM) LH levels. \*\*\*p\<0.001, two-way repeated measures ANOVA with Holm-Sidak test. F-J. Representative examples of pulsatile LH secretion in OVX GnRH-Cre mice given saline (**F,G**) or CNO (**I,J**). LH pulses are indicated by asterisks. Mean (± SEM) amplitude (**H**) and frequency (**K**) of LH pulses in saline (n = 8) and CNO (n = 7). \*\*\*p\<0.001,\*p\<0.05 Mann-Whitney U-tests.](elife-53945-fig3){#fig3}

The same strategy employed in AAV-injected OVX GnRH-Cre mice resulted in normal LH pulsatility in saline-treated animals (N = 8)([Figure 3F,G](#fig3){ref-type="fig"}), but a substantial reduction in both the amplitude (p\<0.001, Mann-Whitney test) and frequency (p\<0.05, Mann-Whitney test) of LH pulses in mice receiving CNO (N = 7)([Figure 3H--K](#fig3){ref-type="fig"}). Mean levels of LH were 3.2 ng/ml in saline and 0.7 ng/ml (p\<0.001, Mann-Whitney test) in CNO-treated mice ([Figure 3---figure supplement 1D,E](#fig3s1){ref-type="fig"}). These results suggest that action potential propagation and/or synaptic integration within the distal compartment of hypophysiotropic GnRH neurons is obligatory for the LH surge and strongly facilitatory for pulsatile LH secretion.

Suppression of excitability at the GnRH neuron soma-dendritic zone abolishes the LH surge but has no effect upon pulsatile LH release {#s2-4}
-------------------------------------------------------------------------------------------------------------------------------------

The next experiments were undertaken to assess the importance of the GnRH neuron soma-proximal dendritic zone in pulse and surge secretion. GnRH-Cre mice were injected with AAV2-Retro-hSyn-DIO-hM4D(Gi)-mCherry into the ME as above and a large volume (2 μL) of saline or CNO injected into the rPOA at 16:00 hr ([Figure 4A](#fig4){ref-type="fig"}). Although an LH surge occurred in all saline-treated mice (N = 9)([Figure 4B](#fig4){ref-type="fig"}), this was abolished in mice receiving CNO into the rPOA (N = 10)([Figure 4C,D](#fig4){ref-type="fig"}). The levels of LH were significantly reduced at 19:00, 20:00 and 21:00 time points in CNO-treated GnRH-Cre mice (p\<0.001, two-way repeated ANOVA) ([Figure 4D](#fig4){ref-type="fig"}).

![Chemogenetic inhibition of GnRH neuron soma-proximal dendrite activity suppresses only the LH surge.\
(**A**) Schematic showing experimental protocol in which GnRH-Cre mice are injected with Cre-dependent Flex-hM4D(Gi)-mCherry AAVs bilaterally into the region of the median eminence and, later, CNO injected into the rostral preoptic area (rPOA). MS, medial septum. CNO, Clozapine N-oxide. (**B,C**) LH surge profiles in all GnRH-Cre OVX+E+P female mice following rPOA injection of saline (**C**, n = 9) or CNO (**D**, n = 10). (**D**) Mean (± SEM) LH levels. \*\*p\<0.01, \*\*\*p\<0.001, two-way repeated measures ANOVA with Holm-Sidak test. (**E-H**), Representative profiles of LH pulsatile secretion in GnRH-Cre OVX female mice with rPOA injection of saline (**E, F**) or CNO (**G, H**). LH pulses are indicated by asterisks. Mean (± SEM) LH pulse amplitude (**I**) and frequency (**J**) in GnRH-cre OVX mice with rPOA injection of saline (n = 8) and CNO (n = 9).](elife-53945-fig4){#fig4}

For pulsatile LH secretion, the same injection of saline (N = 8) or CNO (N = 9) into the rPOA of AAV-injected OVX mice 10 min prior to blood sampling was found to have no effect upon pulsatile LH secretion with no differences detected in LH profiles ([Figure 4E--H](#fig4){ref-type="fig"}), mean pulse amplitude ([Figure 4I](#fig4){ref-type="fig"}), frequency ([Figure 4J](#fig4){ref-type="fig"}) or mean LH levels ([Figure 3---figure supplement 1F,G](#fig3s1){ref-type="fig"}). This indicates that the functional integrity of the GnRH neuron soma-dendritic zone is critical for the generation of the GnRH/LH surge but that this is not the case for pulsatile secretion.

To confirm this surprising observation, we repeated the experiment but used an inhibitory optogenetic approach to suppress electrical activity at the GnRH neuron soma-dendritic zone ([Figure 5A](#fig5){ref-type="fig"}). Archaerhodopsin-3 was expressed selectively in GnRH neurons by crossing GnRH-Cre and FLEX-Rosa-CAG-Arch-GFP^+/+^ mouse lines resulting in 96±2% GnRH cell bodies expressing GFP ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}) with extension into the long projections to the ME. Brain slice electrophysiological studies in these mice demonstrated that short periods (1--10 s) of yellow light (593 nm) illumination hyperpolarized and effectively silenced GnRH neuron firing ([Figure 5---figure supplement 1B,C](#fig5s1){ref-type="fig"}). Continuous illumination for periods of minutes also significantly reduced firing but showed variable efficacy ([Figure 5---figure supplement 1E,F](#fig5s1){ref-type="fig"}), while a 10 s on 10 s off pattern of light illumination remained effective in suppressing firing during illumination for minutes ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}).

![Bilateral optogenetic inhibition of GnRH neuron soma-proximal dendrite activity suppresses only the LH surge.\
(**A**) Schematic showing experimental protocol with GnRH-cre^+/-^;Rosa-CAG-Arch-GFP^+/+^ mice with bilateral optic fiber placement in the rostral preoptic area (rPOA). (**B**) Fluorescence images of GnRH neurons expressing Archaerhodopsin (GFP reporter) and GnRH (red) in GnRH-cre^+/-^;Rosa-CAG-Arch3-GFP^+/+^ mice. Scale bar, 20 μm. (**C-E**) LH surge profiles in all control GnRH-cre^+/-^;Rosa-CAG-Arch-GFP^+/+^ OVX+E+P female mice (**C**, n = 11) and those given intermittent (yellow shaded areas) bilateral rPOA 593 nm illumination at 10 Hz (**D**, n = 12) or, as a control, 473 nm (**E**, n = 12). (**F**) Mean (± SEM) LH levels. \*\*\*p\<0.001, two-way repeated measures ANOVA with Holm-Sidak test. (**G-N**) Representative profiles of pulsatile LH secretion in GnRH-cre^+/-^;Rosa-CAG-Arch3-GFP^+/+^ OVX female mice given 40 min (shaded areas) bilateral rPOA illumination at 593 nm (**G, H**) or, as a control, 473 nm (**K, L**). LH pulses are indicated by asterisks. Mean (± SEM) LH pulse amplitude and frequency are given for yellow (**I,J**, n = 7) and blue (**M,N**, n = 6) light illumination. (**O,P**) Mean (± SEM) LH levels in GnRH-cre^+/-^;Rosa-CAG-Arch-GFP^+/+^ OVX mice with bilateral rPOA laser illumination at 593 nm (**O**, n = 7) or 473 nm (**P**, n = 6).](elife-53945-fig5){#fig5}

The LH surge occurs with the same profile of wild-type mice in GnRH-Cre^+/-^;FLEX-Rosa-CAG-Arch-GFP^+/+^ mice ([Figure 5---figure supplement 2A--B](#fig5s2){ref-type="fig"}). As this event is prolonged, we used an intermittent 593 nm light illumination strategy over 4.5 hr bilaterally into the rPOA to control the activity of the GnRH neurons between 16:00 and 20:30 hr ([Figure 5D](#fig5){ref-type="fig"}). This consisted of a '30 min on, 30 min off' protocol with 10 Hz light given '10 s on, 10 s off' predicted ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}) to stop electrical activity every alternate 10 s during each '30 min on' period. Control experiments showed that i) implanted OVX+E+P wild-type mice given this illumination strategy exhibited a normal LH surge ([Figure 5---figure supplement 2C--E](#fig5s2){ref-type="fig"}), ii) implanted OVX+E+P GnRH-Cre^+/-^;FLEX-Rosa-CAG-Arch-GFP^+/+^ mice without laser illumination exhibited normal LH surges (N = 11) ([Figure 5C](#fig5){ref-type="fig"}) and iii) implanted OVX+E+P GnRH-Cre^+/-^;FLEX-Rosa-CAG-Arch-GFP^+/+^ mice given incorrect 473 nm blue light illumination also had normal LH surges ([Figure 5E,F](#fig5){ref-type="fig"}). In contrast, the LH surge was abolished completely with bilateral yellow light illumination of the rPOA (N = 12)([Figure 5D,F](#fig5){ref-type="fig"}).

As LH pulses in this OVX model occur approximately every 15 min, we reasoned that a continuous 10 Hz light illumination of the rPOA for 40 min would be sufficient to evaluate the effect of suppressing soma-proximal dendrite activity on LH pulsatility. Control experiments demonstrated that this laser illumination strategy did not alter pulsatile LH secretion in wild-type mice ([Figure 5---figure supplement 2F,I](#fig5s2){ref-type="fig"}) with pulse amplitude ([Figure 5---figure supplement 2G,J](#fig5s2){ref-type="fig"}), frequency ([Figure 5---figure supplement 2H,K](#fig5s2){ref-type="fig"}) and mean LH levels ([Figure 5---figure supplement 2L,M](#fig5s2){ref-type="fig"}) all remaining unchanged. Three-minute tail tip blood samples were taken from OVX GnRH-Cre^+/-^;FLEX-Rosa-CAG-Arch-GFP^+/+^ mice for 2 hr with bilateral 593 nm yellow light illumination of the rPOA occurring from 40 to 80 min. This was found to have no effect on pulsatile LH secretion ([Figure 5G,H](#fig5){ref-type="fig"}) with pulse amplitude ([Figure 5I](#fig5){ref-type="fig"}), frequency ([Figure 5J](#fig5){ref-type="fig"}) and mean LH levels ([Figure 5O](#fig5){ref-type="fig"}) remaining unchanged during the illumination period. As a control, the same mice were also illuminated with 473 nm blue light with no effects on pulsatile LH secretion being detected ([Figure 5K--N,P](#fig5){ref-type="fig"}). These observations parallel those of the POA chemogenetic inhibition strategy with optogenetic suppression of soma-proximal dendritic excitability abolishing the LH surge but having no effect upon LH pulsatility.

Discussion {#s3}
==========

It is well established that dendritic computations and integration across both local and global scales are critical for generating precise patterns of neural activity ([@bib44]). We demonstrate here an unusual scenario in which the GnRH neuron utilizes anatomically distinct dendritic compartments to generate its two different modes of secretion: the pulse and surge. Whereas global or local distal dendron inhibition of hypophysiotropic GnRH neurons prevents the surge and greatly reduces pulsatile secretion, local soma-proximal dendrite inhibition abolishes the surge but has no effect on pulses. This indicates that the soma and proximal dendrites of the GnRH neuron are critical for the occurrence of the GnRH surge, whereas the distal dendritic zones are sufficient on their own for generating pulsatile release.

The use of chemogenetic and optogenetic inhibitory approaches require careful controls due, primarily, to the possibility of off-target effects of clozapine derived from CNO ([@bib12]) and the potential warming of brain tissue by lasers ([@bib33]). We have previously reported that CNO administered to wild-type mice has no impact upon pulsatile LH secretion ([@bib7]) and demonstrate here that, equally, CNO has no impact on the LH surge in wild-type mice. This indicates that CNO and its derivatives are unable to modulate the GnRH neuronal network in the absence of a CNO-activated receptor. We have also performed both yellow and blue light laser controls in these studies and show that the activating yellow light has no impact on LH pulses or the LH surge in wild-type mice and that switching to the incorrect wavelength blue light in Arch3-expressing mice is similarly without impact on either mode of secretion.

Substantial evidence indicates that the GnRH surge arises from direct synaptic activation of the soma-proximal dendritic region of rPOA GnRH neurons. The majority of hypophysiotropic GnRH neurons in the rPOA express cFos at the time of the GnRH/LH surge ([@bib18]) and evidence suggests that neighboring kisspeptin neurons provide a key stimulatory synaptic input to the GnRH neuron at this time (for review see [@bib14]; [@bib29]). This concept is supported here by the observation that both chemogenetic and optogenetic inhibition of GnRH neurons within the rPOA abolishes the LH surge. It is notable that the optogenetic activation of archaerhodopsin-3 does not completely suppress firing but entrains a 10 s on 10 s off pattern of firing every 30 min. As this was effective in stopping the surge, this suggests that the overall pattern of GnRH neuron firing may be more important than any average firing rate for surge induction. We also note that the chemogenetic inhibition of the distal GnRH projections was effective in blocking the LH surge indicating that action potential transmission to the GnRH terminals and/or further synaptic integration at the distal dendritic zone is necessary for the surge.

Accruing evidence has supported the possibility that the long, blended dendrite/axon (dendron) projections of GnRH neurons may represent an autonomous regulatory centre close to the GnRH secretory zone in the median eminence. Prior electron microscopic investigations have revealed the presence of synapses on these distal dendrons ([@bib32]) and, using expansion microscopy, we show here that the density of synaptic inputs at the distal dendrons is double that of the proximal dendrite. Thus, the distal dendron appears to be the most densely innervated dendritic compartment of the GnRH neuron. Studies in the brain slice indicate that GABA, glutamate and kisspeptin are all active in regulating the activity of the GnRH neuron distal dendron ([@bib16]; [@bib19]). Furthermore, it seems very likely that the arcuate nucleus (ARN) kisspeptin neurons target this dendritic zone to generate pulsatile GnRH/LH secretion ([@bib15]; [@bib36]).

The inhibition strategies used in this study are not able to determine whether changes in GnRH secretion arise from alterations in intrinsic excitability or synaptic integration in the GnRH neuron; both will ultimately be inhibited by hyperpolarization of the dendron. However, it seems very likely that the suppression of episodic GnRH secretion results from alterations in synaptic integration; first, there is very little evidence that the intrinsic properties of adult GnRH neurons contribute to the generation of LH pulses ([@bib15]). Second, we show here that there is substantial synaptic density at the dendron and third, there is robust evidence in several species for the kisspeptin neuron pulse generator to operate synaptically to drive LH pulses ([@bib15]; [@bib31]; [@bib36]).

We find here that the local chemogenetic inhibition of distal GnRH neuron projections in and around the median eminence exerts a very substantial suppression of pulsatile LH release but it does not stop entirely. Notably, the same result was observed with chemogenetic inhibition of the entire GnRH neuron. This may result from the CNO activation of G~i~ signalling within GnRH distal projections being insufficient to arrest completely the potent G~q/11~-mediated effects of kisspeptin on both TRPC and voltage-gated calcium channels in the dendron ([@bib19]; [@bib40]).

Neither chemogenetic nor optogenetic inhibition of rPOA GnRH neuron soma and dendrites had any effect on pulsatile LH secretion despite abolishing the LH surge. This demonstrates that the soma and proximal dendritic compartments of rPOA GnRH neurons are not required for the generation of LH pulses. As the action potential initiation zones for GnRH neurons are only located in these proximal regions ([@bib17]; [@bib16]), this suggests that the propagation of action potentials down the dendron are not required for pulsatile secretion. This is compatible with the demonstration of episodic GnRH secretion in in vitro preparations without GnRH cell bodies ([@bib37]). Although we infused large volumes of CNO into the rPOA, that would have been expected to infiltrate the entire region, it remains that hypophysiotropic GnRH neurons located in the dorsal aspects of the medial septum and caudal-most in the MBH may have been unaffected. It is possible that these few GnRH neurons are not necessary for surge generation but are, nevertheless, able to maintain pulsatile LH secretion. However, this seems unlikely as reducing the number of hypophysiotropic GnRH neurons has a marked effect on LH pulse amplitude ([@bib8]) and we saw no change in LH pulse amplitude following either inhibition strategy.

It has recently become clear that the pulse generator is formed by ARN kisspeptin neurons that are intermittently synchronized and send excitatory projections to the GnRH neuron distal dendron in the mouse ([@bib6]; [@bib15]; [@bib31]; [@bib36]). This kisspeptin activation of the GnRH neuron distal dendrons and consequent GnRH secretion in the ME has repeatedly been shown to occur in the absence of action potential generation ([@bib9]; [@bib11]; [@bib19]). As such, it seems highly likely that the synaptic innervation of the distal dendron represents a highly localized, autonomous regulatory mechanism for the generation of pulsatile GnRH/LH secretion. The present observations provide the first in vivo evidence in support of this concept and demonstrate a novel mechanism for the synchronization of neural output within the forebrain. It is possible that this unusual situation arises from the unique embryonic migration of the GnRH neurons from the nose into the brain resulting in their somata being scattered throughout the basal forebrain but their projections being concentrated together just above the ME ([@bib47]). The robust synaptic innervation of these clustered distal dendronic projections likely provides an efficient solution for the afferent synchronization of an otherwise widely dispersed neural population.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                           Designation                                                   Source or reference                     Identifiers                                                                       Additional information
  (species) or resource                                                                                                                                                                                                           
  --------------------------------------- ------------------------------------------------------------- --------------------------------------- --------------------------------------------------------------------------------- ------------------------
  Genetic reagent (*M. musculus*)         STOCK Tg(Gnrh1-cre)1Dlc/J                                     Jackson Laboratory                      Stock \#: 021207\                                                                 
                                                                                                                                                RRID:[IMSR_JAX:021207](https://scicrunch.org/resolver/IMSR_JAX:021207)            

  Genetic reagent (*M. musculus*)         B6;129S-Gt(ROSA)26Sor^tm35.1(CAG-AOP3/GFP)Hze^/J              Jackson Laboratory                      Stock \#: 012735\                                                                 
                                                                                                                                                RRID:[IMSR_JAX:012735](https://scicrunch.org/resolver/IMSR_JAX:012735)            

  Genetic reagent (*M. musculus*)         B6.DBA-Tg(Gnrh1-EGFP)1Phs                                     [@bib41]                                MGI:6158458\                                                                      

  Transfected construct (*M. musculus*)   AAV2-Retro-hSyn-DIO-hM4D(Gi)-mCherry                          OBiO Technology (Shanghai) Corp., Ltd   RRID:[Addgene_44362](https://scicrunch.org/resolver/Addgene_44362)                

  Antibody                                polyclonal guinea pig anti-GnRH antisera                      gift G. Anderson, University of Otago   Cat \#GA02\                                                                       (1: 5000)
                                                                                                                                                RRID:[AB_2721118](https://scicrunch.org/resolver/AB_2721118)                      

  Antibody                                polyclonal rabbit anti-GnRH antisera                          gift G. Anderson, University of Otago   Cat \#GA01\                                                                       (1: 5000)
                                                                                                                                                RRID:[AB_2721114](https://scicrunch.org/resolver/AB_2721114)                      

  Antibody                                Alexa Fluor 488-AffiniPure Donkey Anti-Guinea Pig IgG (H+L)   Jackson ImmunoResearch Labs             Cat\# 706-545-148, RRID:[AB_2340472](https://scicrunch.org/resolver/AB_2340472)   (1:500)

  Antibody                                Alexa Fluor 594 donkey anti-rabbit antibody                   Jackson ImmunoResearch Labs             Cat\# 711-585-152, RRID:[AB_2340621](https://scicrunch.org/resolver/AB_2340621)   (1:500)

  Antibody                                DAPI (4\',6-Diamidino-2-Phenylindole, Dilactate) antibody     Thermo Fisher Scientific                Cat\# D3571,\                                                                     300 nM
                                                                                                                                                RRID:[AB_2307445](https://scicrunch.org/resolver/AB_2307445)                      

  Antibody                                Anti-GFP (chicken polyclonal)                                 Abcam                                   Cat\# AB13970\                                                                    (1:8000)
                                                                                                                                                RRID:[AB_300798](https://scicrunch.org/resolver/AB_300798)                        

  Antibody                                Anti-Synaptophysin 1 (guinea pig polyclonal)                  Synaptic Systems                        Cat\#101004\                                                                      (1:800)
                                                                                                                                                RRID:[AB_1210382](https://scicrunch.org/resolver/AB_1210382)                      

  Antibody                                Anti-Vesicular GABA Transporter (rabbit polyclonal)           Synaptic Systems                        Cat\#131003\                                                                      (1:800)
                                                                                                                                                RRID:[AB_887869](https://scicrunch.org/resolver/AB_887869)                        

  Antibody                                Anti- Gephyrin (guinea pig polyclonal)                        Synaptic Systems                        Cat\#147318\                                                                      (1:800)
                                                                                                                                                RRID:[AB_2661777](https://scicrunch.org/resolver/AB_2661777)                      

  Antibody                                Goat anti-chicken (goat polyclonal, Alexa488-conjugate)       Thermo Fisher Scientific                Cat\# A-11039\                                                                    (1:200)
                                                                                                                                                RRID:[AB_2534096](https://scicrunch.org/resolver/AB_2534096)                      

  Antibody                                Goat anti-guinea pig (goat polyclonal, biotin-conjugated)     Vector Laboratories                     Cat\# BA-7000\                                                                    (1:200)
                                                                                                                                                RRID:[AB_2336132](https://scicrunch.org/resolver/AB_2336132)                      

  Antibody                                Goat anti-rabbit (goat polyclonal, ATTO647N-conjugated)       Sigma-Aldrich                           Cat\# 40839\                                                                      (1:200)
                                                                                                                                                RRID:[AB_1137669](https://scicrunch.org/resolver/AB_1137669)                      

  Chemical compound, drug                 Beta-Estradiol 3-benzoate                                     Sigma Aldrich                           E8515                                                                             

  Chemical compound, drug                 Beta estradiol                                                Sigma Aldrich                           E8875                                                                             

  Chemical compound, drug                 progesterone                                                  Sigma Aldrich                           P0130                                                                             

  Chemical compound, drug                 clozapine-N- oxide                                            Sigma Aldrich                           C0832                                                                             

  Software, algorithm                     GraphPad Prism software                                       GraphPad Prism                          RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)                      Version 6.01

  Software, algorithm                     ImageJ image analysis software                                ImageJ\                                 RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070)                      
                                                                                                        (<https://imagej.net/>)                                                                                                   

  Software, algorithm                     Vaa3D data visualization software                             Vaa3D\                                  RRID:[SCR_002609](https://scicrunch.org/resolver/SCR_002609)                      
                                                                                                        (<http://www.vaa3d.org>)                                                                                                  
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

Adult littermate heterozygous *Gnrh1*-Cre^+/−^ mice with Cre recombinase targeted to the first coding exon of *Gnrh1* ([@bib48])(JAX \#021207), alone or crossed onto Cre-dependent reporter ROSA26-CAG-Arch3-GFP lines ([@bib25])(JAX \#012735) (C57BL/6J genetic background), were housed under a 12:12 hr lighting schedule (lights on at 07:00-19:00) with ad libitum access to food and water. Genotypes were determined by PCR of mouse tail DNA samples. All animals were maintained and treated in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by Animal Care and Use Committee of Shanghai JiaoTong University School of Medicine (2016--0016). Female C57BL/6 GnRH-GFP mice ([@bib41]) were housed under a 12:12 hr lighting schedule (lights on at 07:00-19:00) with ad libitum access to food and water at the University of Otago Hercus-Taieri Breeding Unit. All experiments were approved by the University of Otago Animal Welfare and Ethics Committee (96/17).

Expansion microscopy synaptic density experiments {#s4-2}
-------------------------------------------------

Diestrus GnRH-GFP mice were anaesthetized with pentobarbital and perfused transcardially with 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS; pH 7.6). Brains were post-fixed in the same fixative at room temperature for 1 hr and rinsed in 0.1 M PBS. Coronal brain sections (50 μm thick) were cut on a vibratome in Tris-buffered saline (TBS) and treated with 0.1% Triton-X-100% and 2% goat serum overnight at 4°C followed by 0.1% sodium borohydrate in TBS for 15 min at room temperature, then washed and incubated for 72 hr at 4°C with well-characterized chicken anti-GFP (1:8,000; Abcam, AB13970) ([@bib10]) and guinea-pig anti-synaptophysin 1 (1:800, Synaptic Systems, 101004) ([@bib45]) or rabbit anti-vesicular GABA transporter (VGAT, 1:800, Synaptic Systems, 131003) ([@bib26]) and guinea pig anti-gephyrin (1:800, Synaptic Systems, 147318) ([@bib34]) antisera in TBS containing 0.3% Triton-X-100, 0.25% bovine serum albumin and 2% goat serum. Sections were then washed and incubated with biotinylated rabbit anti-guinea pig immunoglobulins (1:200, Vector Laboratories), Alexa488-conjugated goat anti-chicken (1:200, ThermoFisher Scientific) and ATTO647N goat anti-rabbit immunoglobulins (Sigma-Aldrich) for 15 hr at 4°C. Omission of primary antibodies resulted in no detectable immunofluorescence. Sections were then expanded using a protocol similar to that published previously ([@bib4]; [@bib5]). In brief, trimmed immunostained sections underwent linking with anchoring agent (MA-NHS; 2 mM) for 1.5 hr before being incubated in monomer solution (1x PBS, 2 M NaCl, 8.625% (w/w) sodium acrylate, 2.5% acrylamide, 0.15% N,N′-methylenebisacrylamide) on ice for 45 min. Sections were then immersed in gelling solution (monomer solution added with 0.01% 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl + 0.2% tetramethylethy lenediamine + 0.2% ammonium persulfate) and incubated in a humidified chamber at 37°C for 2 hr. Gel-embedded sections were trimmed and digested overnight with 8 U/mL Proteinase K in digestion buffer at 37°C and then rinsed in PBS and incubated with Strepavidin-568 at 37°C for 3 hr. Expansion was undertaken by adding water every 20 min, up to five times.

Images were acquired using a Nikon A1R upright confocal microscope equipped with a water-immersion lens (25x Numerical Aperture 1.1; Working Distance 2 mm) using sequential scanning mode and image stacks collected with 600 nm focus intervals. Sixteen-bit confocal images (1024 × 512 pixel format) were analyzed using ImageJ to determine the number of synaptophysin-immunoreactive boutons apposing GnRH neuron dendrites and the expansion factor. For the soma-dendritic zone, contiguous 250 μm (60 μm pre-expansion) lengths of primary dendrite arising from the GnRH cell body were selected at random from three rostral preoptic area sections in each of the four mice. Each apposing synaptophysin bouton (diameter \>0.4 μm) was examined in three dimensions to establish the best side-on or face-on view of the imaged synapse. A line scan was then performed across this plane and the relative intensity of the Alexa488 and ATTO647 measured and plotted in Microsoft Excel. An apposition was considered a synapse where the signals overlapped by \>0.95 μm (0.23 μm pre-expansion) in the side-on plane or by \>1.75 μm (0.42 μm pre-expansion) in the face plane. The same process was used to establish the synaptic density for the distal dendron using 60 μm (15 μm pre-expansion) contiguous lengths of dendron located in the ventral arcuate nucleus immediately lateral to the margin of the median eminence ([@bib32]). Three-dimensional reconstruction of GnRH dendrites displaying synaptic inputs was undertaken with Vaa3D ([@bib35]).

Stereotaxic injections of AAVs and implantation of cannula or fibre optic {#s4-3}
-------------------------------------------------------------------------

For the chemogenetic inhibition studies, recombinant cre-dependent AAVs encoding hM4Di (AAV2-Retro-hSyn-DIO-hM4D(Gi)-mCherry, 5 × 10^12^ GC/mL; OBiO Technology (Shanghai) Corp., Ltd) were injected bilaterally into the region of the ME of GnRH-Cre^+/−^ mice. Adult female mice (8--12 weeks) were anesthetized with 2% isoflurane, and placed in a stereotaxic apparatus. A Hamilton syringe apparatus holding a 10 μL Hamilton syringe with 25-gauge needle was used to perform bilateral injections. The stereotaxic coordinates were: AP −1.7 mm; ML ±0.3 mm; DV −5.8 mm. The needle was lowered into place and 1 μL AAV injected over 5 min, and the needle was left in situ for a further 5 min before being withdrawn. As appropriate, customized bilateral guide cannulae (RWD Life Science) were then implanted into the region of the ME (AP −1.7 mm; ML ±0.3 mm; DV −5.3 mm), or customized unilateral cannula guides (RWD Life Science) were implanted to the POA (AP 0.6 mm; ML ±0.0 mm; DV −4.5 mm).

For the optogenetic inhibition, female GnRH-Cre^+/-^;Flex-Rosa-CAG-Arch3-GFP^+/+^ mice aged 8--12 weeks were anesthetized with 2% isoflurane, placed in a stereotactic instrument and customized bilateral optic fibers (200 μm diameter, pitch 0.7 mm, 0.37 N.A.; Doric Lenses, Canada) implanted into the rPOA (AP 0.6 mm; ML ±0.35 mm; DV −4.5 mm) and secured with dental cement. All mice were given at least 14 days to recover before OVX surgery.

LH pulse and surge models {#s4-4}
-------------------------

At least 2 weeks after cranial surgery, female GnRH-Cre^+/−^ and GnRH-Cre^+/-^;Rosa-CAG-Arch3-GFP^+/+^ mice were ovariectomized and 1 week later used for 3-min interval tail tip bleeding experiments from 9:00 AM to 11:00 AM to assess LH pulsatility ([@bib8]). To model the LH surge, AAV-injected and implanted mice were ovariectomized and given a s.c. SILASTIC capsule filled with 1 µg/20 g b.w. 17-β-estradiol that generates negative feedback ([@bib8]). Six days later, mice were given an injection of estradiol benzoate (1 µg/100 µL, s.c.) at 09:00. The following day, mice were given an injection of progesterone (500 µg/100 µL) at 09:00 and hourly tail-tip bleeding was performed from 16:00 to 21:00 in initial experiments and then at 16;00, 19:00, 20:00 and 21:00 in experimental mice. Lights went out at 19:00. Repetitive tail-tip pulse blood sampling was undertaken using the method of [@bib43]. In brief, after a single excision of the very tip of the tail, mice were gently restrained in a cardboard tube every 3 min while their tail was wiped clean with saline and then massaged so that a second investigator could take a 6-μL blood sample from the tail tip with a pipette. Whole blood was immediately diluted in 114 μL of 0.1M PBS with 0.05% Tween 20, vortexed, and snap frozen on dry ice. Samples were stored at −20°C for a subsequent LH ELISA ([@bib43]). LH pulses were identified as an increment in LH values from nadir to peak over 25% (peak minus nadir)/nadir x100). Studies using GCaMP photometry assessments of GnRH pulse generator activity in short-term OVX mice show that every increment in LH \>25% using this tail-tip procedure is correlated with a pulse generator event and represents a bone fide LH pulse ([@bib6]; [@bib27]).

Chemogenetic inhibition experiments {#s4-5}
-----------------------------------

Intraperitoneal injections of CNO (2 mg/kg \[[@bib1]\], Sigma) or saline were given at 16:00, 3 hr before lights off in LH surge experiments, or 1 hr before blood sampling in LH pulse experiments. Intracranial injections of CNO or saline were given through bilateral or unilateral infusion cannulae (1 µL each side in ME or 2 µL in rPOA; 6 μM CNO \[[@bib42]\]) at 16;00, 3 hr before lights off in LH surge experiment, or 10 min before beginning blood sampling in LH pulse experiments.

Brain slice electrophysiology {#s4-6}
-----------------------------

GnRH-cre^+/-^;Rosa-CAG-Arch-GFP^+/+^ mice (P21-P35) were briefly anesthetized with isoflurane and brains dissected out and immediately immersed into ice-cold Gey's balanced salt solution (NaCl 130, KCl 4.9, CaCl~2~ 1.5, MgSO~4~ 0.3, MgCl~2~ 11, KH~2~PO~4~ 0.23, Na~2~HPO~4~ 0.775, glucose 5, HEPES 25, NaHCO~3~ 22 and NaOH 12 (in mM), pH = 7.2, oxygenated with 95% O~2~/5% CO~2~) for 3 min. The 300 μm-thick coronal slices were sectioned on vibratome (VT-1000s, Leica, Germany) in ice-cold Gey's balanced salt solution and transferred to a holding chamber filled with room-temperature artificial cerebrospinal fluid (ACSF, NaCl 124, KCl 3, CaCl~2~ 2, MgCl~2~ 1, NaH~2~PO~4~ 1.25, NaHCO~3~ 26 and glucose 10 (in mM), pH = 7.3, oxygenated with 95% O~2~ and 5% CO~2~). After a recovery of 30 min, slices were transferred to a recording chamber constantly superfused with oxygenated ACSF and neurons recorded.

GnRH neurons were identified by GFP expression with a 40x objective under the blue light which was generated from the mercury lamp (C-HGFI, Nikon, Japan) and filtered by fluorescence cubes (470/20 nm, Zeiss Inc, Germany). Under a Zeiss upright DIC microscope (Examiner A1, Zeiss, Germany), neurons were patched with a glass pipette (5--10 MΩ) pulled by P-97 micropipette puller (Sutter Instruments, USA). The pipette solution contained the following (in mM): potassium gluconate 105, KCl 5, CaCl~2~ 0.5, MgCl~2~ 2, EGTA 5, HEPES 10, Mg-ATP 4, GTP-Na 0.5, sodium phosphocreatine 7, Lucifer Yellow 0.05%, pH 7.4 adjusted with KOH. After establishing the whole-cell configuration, 100 ms current was injected to probe the action potential threshold, and the optogenetic inhibition was tested at 25 pA above rheobase. Various patterns of 593 nm light pulses at \~5 mW/mm (Polygon-400, Mightex, USA) were delivered through the water immersion 40x objective to optically inhibit the Arch-expression neurons. Recordings were performed using MultiClamp 700B patch-clamp amplifier (Molecular Devices, USA), digitized by Digidata 1440 (Molecular Devices, USA), and analyzed by pClamp 10 (Molecular Devices, USA).

Optogenetic inhibition experiments {#s4-7}
----------------------------------

GnRH-Cre^+/-^;Rosa-CAG-Arch3-GFP^+/+^ mice were attached to the laser patch cord in their home cages and left to acclimate for 15 min, and 3 min blood sampling (6 μL per sample) undertaken for 120 min as described above. For optogenetic inhibition in LH surge experiments, a '30 min on, 30 min off' protocol with 10 Hz 593 nm laser light (10 s on, 10 s off) was used from 16:00 to 20:30. In the LH pulse experiments, blood sampling was undertaken for 120 min with an initial 40 min followed by yellow light illumination for 40 min and a final 40 min period without light. The DPSS laser (593 nm, ∼5 mW per fiber; Shanghai Dream Lasers Technology Co., Ltd.) was controlled by a stimulator (RIGOL Technologies, Inc). After 1 week, mice received a second experiment in which they received control blue light illumination (473 nm, ∼5 mW per fiber; Shanghai Dream Lasers Technology Co., Ltd.) in the same manner as for yellow light.

Immunofluorescence {#s4-8}
------------------

Coronal brain sections covering the full length of the rPOA and MBH were used to determine the locations of cannula/fibre optic and/or processed for dual-label analysis. Mice were anesthetized with choral hydrate and perfused with saline followed by 4% paraformaldehyde in 0.1M PBS. The brains were quickly removed, post-fixed in 4% paraformaldehyde overnight, and subjected to dehydration in increasing saccharin solutions (20--30%) at 4°C. The frozen brain slices were sectioned at 25 μm on a vibratome (Leica). Brain sections were placed in 3% normal goat serum and 0.2% Triton-X for 1 hr and then incubated in polyclonal guinea pig or rabbit anti-GnRH antisera (1:5000, gift from Greg Anderson, University of Otago) overnight at 4°C. Slices were rinsed in PBS then incubated in donkey anti-guinea pig Alexa-488 antibody (Jackson Immunoresearch) in GnRH-cre^+/-^::Flex-hM4D(Gi) mice or donkey anti-rabbit Alexa-594 antibody (Jackson Immunoresearch) in GnRH-cre^+/-^;Rosa-CAG-Arch-GFP^+/+^ mice for 1 hr and 4\',6-diamidino-2-phenylindole (DAPI, Invitrogen) for 10 min, then mounted after rinsing. Dual fluorescence images were captured on an Olympus FV3000 confocal microscope.

Statistical analysis {#s4-9}
--------------------

Statistical analyses were carried out with GraphPad Prism (GraphPad Software). When comparing the amplitude and frequency of LH pulse within two groups, data were compared using Mann-Whitney test. When comparing the amplitude and frequency of LH pulse within three groups, data were compared using parametric one-way ANOVA (with post hoc Tukey's multiple comparisons test). The firing rate and LH surge profiles were assessed using repeated-measures ANOVA. Differences were considered significant for p\<0.05. Values are given as mean ± SEM.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This paper provides novel and provocative data that will be of interest to the field.

**Decision letter after peer review:**

Thank you for submitting your article \"Different dendritic domains of the GnRH neuron underlie the pulse and surge modes of GnRH secretion\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Catherine Dulac as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

Studies in the past decade have demonstrated a curious structure of GnRH neurons where the distal dendrite has partly axon-like properties (\"the dendron\"). This impressive work has generated some intriguing questions about the control of the gonadotropic axis. Among them is the relative role of different GnRH neuron compartments for the distinct modes of LH secretion, leading to the proposal that the distal dendrite is ideally situated and equipped to integrate upstream input that may constitute the GnRH pulse generator (rather than being intrinsically generated by GnRH neuronal activity). Wang and colleagues describe results from a series of studies investigating the distinct physiological roles of distinct dendritic segments in GnRH neurons.

Previous work in other systems (e.g. Govindaiah and Cox, 2004) has shown how the dendrite can act as a separate, isolated compartment from the rest of the neuron. However, the work on the GnRH system takes this concept a significant step further in showing that this compartmentalized activity can underlie functionally distinct modes of operation (pulse vs. surge). They use a combination of expansion microscopy, chemo- and optogenetic approaches and provide data that activity in proximal dendrites and distal dendrites have distinct responses. They report that (1) GnRH neurons have more synapses on their distal (compared to proximal) dendrites; (2) excitability of distal dendrite controls both pulsatile and surge mode of LH secretion; (3) excitability of soma/proximal dendrite controls surge mode of LH secretion. There are, however, concerns about the design of the study and controls that need to be addressed in order to support the conclusions.

Essential revisions:

Given that CNO diffuses readily in the body (as proved -- multiply in the field, and also in this paper -- by its effectiveness in the brain when it is given i.p.), what is the evidence or rationale that CNO injected into MBH stays locally in the MBH rather than spreads broadly? Even if CNO binding to DREADD receptor was locally confined (which seems highly improbable), is there any evidence that CNO-induced inhibition stays confined to distal dendron (this also seems unlikely given that DREADD receptor is coupled to diffusible intracellular messengers)? Given that conclusions of the authors are based on the assumption that CNO action is spatially restricted, this seems an important concern.

The chemogenetic approach is powerful, but has been under some criticism recently, with concerns about specificity and sensitivity. Missing from this study is an in vitro validation to demonstrate that application of CNO indeed hyperpolarizes GnRH neurons. Were CNO controls included to exclude effects of metabolism of CNO causing effects? In particular see Gomez et al., 2017.

In Figure 2G, it looks as if the peak was delayed in CNO-treated wild-types. Likewise, even though the CNO-treated tg mouse is largely flat in its curve, it looks as if there is a small increase at 20-21h vs at 19h. Can the authors please comment on this? I note also that in Figure 2H-M no wildtype animals injected with CNO were included as controls.

The optogenetic inhibition experiments have been validated in slices. But the effect seems quite modest. If I read Figure 5---figure supplement 1F correctly, this manipulation decreases firing frequency from ca. 2 to 1 Hz. Indeed, full suppression is difficult to accomplish with continuous illumination owing to the properties of Arch, but in the end, this experiment is difficult to evaluate, since the decrease in firing appears so limited. Can the authors please address how they believe this manipulation, which seems likely to more change the pattern of output of GnRH, rather than dramatically alter the amount of GnRH release, affects LH secretion?

Further issues with controls: blue light was used as a control for the absence of effect of yellow light upon Arch activation in the rPOA on pulsatility (Figure 5F-I and J-M). But this control seems more relevant to include when assessing the effect on surge (to show that blue light does not abolish surge), i.e. to complement Figure 5D-E.

Did the authors perform a negative control (laser in mice without opsins)? E.g. see Owen et al., 2019.
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Author response

> Essential revisions:
>
> Given that CNO diffuses readily in the body (as proved -- multiply in the field, and also in this paper -- by its effectiveness in the brain when it is given i.p.), what is the evidence or rationale that CNO injected into MBH stays locally in the MBH rather than spreads broadly? Even if CNO binding to DREADD receptor was locally confined (which seems highly improbable), is there any evidence that CNO-induced inhibition stays confined to distal dendron (this also seems unlikely given that DREADD receptor is coupled to diffusible intracellular messengers)? Given that conclusions of the authors are based on the assumption that CNO action is spatially restricted, this seems an important concern.

Indeed, it is critical that the sphere of CNO action is spatially restricted. To our knowledge, the first to undertake a robust assessment of this issue was Stachniak and colleagues (Neuron, 2014) where they showed that intracerebral injections of 3 µM CNO into the paraventricular nucleus had a radius of action in the order of 3-50 µm. While we have not performed similar experiments ourselves, we expect that the 6 µM CNO we injected into the POA would have much the same spread. Indeed, it is clear from our experiments that CNO injected into the POA does not reach sufficient concentrations in the MBH; CNO injected into the POA has no effect on LH pulses whereas CNO injected into the MBH blocks LH pulses. Thus, we feel confident that there is not substantial diffusion of effective CNO from one site to another. We would also note that the amount of CNO injected peripherally (0.15 micromoles) is \~10,000x greater than that injected into the POA or MBH (12 picomoles).

> The chemogenetic approach is powerful, but has been under some criticism recently, with concerns about specificity and sensitivity. Missing from this study is an in vitro validation to demonstrate that application of CNO indeed hyperpolarizes GnRH neurons. Were CNO controls included to exclude effects of metabolism of CNO causing effects? In particular see Gomez et al., 2017.

We had just begun to undertake the in vitro validation requested when the COVID19 pandemic struck and all work was suspended. To date we only have a single recording that shows the expected suppression of GnRH neuron firing by CNO (trace shown in [Author response image 1](#sa2fig1){ref-type="fig"}) but it is unclear when this work can resume. Many studies have shown suppressive effects of CNO on neural activity both in vivo and vitro (see Smith et al., 2016 for recent review) and we do not believe this is a contentious enough issue to hold up publication of the study. We would be willing to ascribe to the COVID19 *eLife* policy of completing this control when able and posting the result.

The potential effects of clozapine are certainly something to be wary of with this approach. However, we note that CNO given to wild-type, AAV-injected controls has no effect on the LH surge (Figure 2D) indicating that clozapine (or indeed CNO itself) has no impact upon this neural network in our treatment protocol. Other studies in our laboratory (Coutinho et al., 2019) have also shown that intraperitoneal CNO has no effects on pulsatile LH secretion in wild-type mice. Thus, CNO and its metabolites have no effect on either the pulsatile or surge patterns of LH secretion in the absence of the CNO-gated receptor. We have now included reference to this important point in the manuscript.

![Cell-attached recording of a GnRH neuron from an AAV-injected mouse showing the effect of 1 μM CNO on firing.](elife-53945-resp-fig1){#sa2fig1}

> In Figure 2G, it looks as if the peak was delayed in CNO-treated wild-types. Likewise, even though the CNO-treated tg mouse is largely flat in its curve, it looks as if there is a small increase at 20-21h vs at 19h. Can the authors please comment on this? I note also that in Figure 2H-M no wildtype animals injected with CNO were included as controls.

There are no significant differences between the LH surge profiles of saline- and CNO-treated wild-type mice at any of the time points indicating that there is no effect of CNO alone on the surge mechanism. Regarding the very small non-significant rise at 20 and 21h in CNO-treated tg mice (Figure 2G), this is due to two of the eleven mice (orange and teal traces) showing a very small late increase in LH. In neither case would this be considered an LH surge (see profiles C-E). As shown in Figure 2G there is a highly significant (P\<0.001) complete ablation of peak LH surge secretion in CNO-treated tg mice compared to all three controls. Regarding the pulses, as noted above, we have previously demonstrated that intraperitoneal CNO has no effects on pulsatile LH secretion and this is now noted.

> The optogenetic inhibition experiments have been validated in slices. But the effect seems quite modest. If I read Figure 5---figure supplement 1F correctly, this manipulation decreases firing frequency from ca. 2 to 1 Hz. Indeed, full suppression is difficult to accomplish with continuous illumination owing to the properties of Arch, but in the end, this experiment is difficult to evaluate, since the decrease in firing appears so limited. Can the authors please address how they believe this manipulation, which seems likely to more change the pattern of output of GnRH, rather than dramatically alter the amount of GnRH release, affects LH secretion?

This is a valid point and we agree with the reviewer that the electrophysiological study shows that the main effect of Arch activation over a prolonged period is to control the pattern of firing rather than suppress activity completely. Indeed, with the 10s on 10s off protocol every 30 min we could reasonably expect GnRH neuron firing to follow this pattern (i.e. an overall 25% decrease) and yet the surge is clearly abolished. This is now raised in the Discussion emphasizing the potential importance of the pattern of GnRH neuron firing.

> Further issues with controls: blue light was used as a control for the absence of effect of yellow light upon Arch activation in the rPOA on pulsatility (Figure 5F-I and J-M). But this control seems more relevant to include when assessing the effect on surge (to show that blue light does not abolish surge), i.e. to complement Figure 5D-E.

We have now undertaken the blue light control experiment during the LH surge as requested. The new Figure 5E shows that OVX+E+P GnRH-Cre^+/-^;FLEX-Rosa-CAG-Arch-GFP^+/+^ mice exhibit normal LH surges with bilateral 473nm blue light illumination in rPOA (N=12).

> Did the authors perform a negative control (laser in mice without opsins)? E.g. see Owen et al., 2019.

Yes, we originally showed that yellow light illumination had no effect on the LH surge in wild-type mice (Figure 5---figure supplement 2C-E). To address LH pulses, we have now undertaken further control experiments and demonstrate that this laser illumination strategy similarly does not alter pulsatile LH secretion (Figure 5---figure supplement 2F-M).

[^1]: These authors contributed equally to this work.
